This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Novartis Ag. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rochestown, IE (2007)
- Horsham, GB (2008)
Company Filing History:
Years Active: 2007-2008
Title: Alastair Denholm: Innovator in Pharmaceutical Chemistry
Introduction
Alastair Denholm is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymes related to inflammatory diseases. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.
Latest Patents
Denholm holds 2 patents that focus on the use of naphthyridine derivatives as phosphodiesterase type 4 (PDE4) inhibitors. His latest patents include:
1. [1,7]naphthyridines as PDE4 inhibitors - This patent describes compounds that are useful for treating conditions mediated by phosphodiesterase type 4 or the down-regulation or inhibition of TNF-α release, particularly in obstructive or inflammatory airways diseases. The patent also details pharmaceutical compositions containing these compounds and the processes for their preparation.
2. Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors - This invention relates to compounds where R is a monovalent aromatic group having up to 10 carbon atoms, and R is a cycloaliphatic group having up to 8 ring carbon atoms. The patent outlines compositions containing these compounds, methods for their preparation, and their use as pharmaceuticals.
Career Highlights
Denholm is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise in medicinal chemistry to create innovative therapeutic solutions.
Collaborations
Throughout his career, Denholm has collaborated with esteemed colleagues such as Thomas Hugo Keller and Clive McCarthy. These collaborations have further enhanced his research and contributed to the advancement of pharmaceutical innovations.
Conclusion
Alastair Denholm's work in the field of pharmaceutical chemistry exemplifies the impact of innovative thinking on healthcare solutions. His patents reflect a commitment to addressing significant medical challenges through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile